Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FCM4K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,989
Award facts
- Contract value 100% obligated
- $72,989.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,989.48 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL), a prescription medication used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions. This competitively awarded, firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Department of Defense healthcare system. As a prime vendor under the DLA Pharmaceutical Prime Vendor Global Program, the company supplies a comprehensive portfolio of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military and veteran healthcare needs worldwide. This delivery order represents routine pharmaceutical procurement activity under the established global pharmaceutical support vehicle that enables DLA to efficiently distribute essential medications to Defense Health Agency and other military healthcare stakeholders.
Quick answers
Who was awarded contract SPE2DR26FCM4K?
SPE2DR26FCM4K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FCM4K worth?
The government has obligated $72,989 on SPE2DR26FCM4K.
Is contract SPE2DR26FCM4K an order under another contract?
Yes. SPE2DR26FCM4K is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCM4K competed?
The extent of competition for SPE2DR26FCM4K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award